-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$1.33-20.36% Downside
Ikena Oncology, Inc. Frequently Asked Questions
-
What analysts cover Ikena Oncology, Inc.?
Ikena Oncology, Inc. has been rated by research analysts at Wedbush in the past 90 days.